3E0Level 3

Administration, Physiological Systems and Anatomical Regions, Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

GET/api/v1/systems/icd10_pcs/nodes/3E0

Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

3E00X05Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach

3E00X0MIntroduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach

3E00X28Introduction of Oxazolidinones into Skin and Mucous Membranes, External Approach

3E00X29Introduction of Other Anti-infective into Skin and Mucous Membranes, External Approach

3E00X3ZIntroduction of Anti-inflammatory into Skin and Mucous Membranes, External Approach

3E00X4ZIntroduction of Serum, Toxoid and Vaccine into Skin and Mucous Membranes, External Approach

3E00XBZIntroduction of Anesthetic Agent into Skin and Mucous Membranes, External Approach

3E00XGCIntroduction of Other Therapeutic Substance into Skin and Mucous Membranes, External Approach

3E00XKZIntroduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach

3E00XMZIntroduction of Pigment into Skin and Mucous Membranes, External Approach

3E00XNZIntroduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach

3E00XTZIntroduction of Destructive Agent into Skin and Mucous Membranes, External Approach

3E0102AIntroduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach

3E01305Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach

3E0130MIntroduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach

3E01328Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach

3E01329Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach

3E0132AIntroduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach

3E0133ZIntroduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach

3E01340Introduction of Influenza Vaccine into Subcutaneous Tissue, Percutaneous Approach

3E0134ZIntroduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach

3E0136ZIntroduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach

3E0137ZIntroduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach

3E013BZIntroduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach

3E013GCIntroduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach

3E013HZIntroduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach

3E013KZIntroduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach

3E013NZIntroduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach

3E013TZIntroduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach

3E013VGIntroduction of Insulin into Subcutaneous Tissue, Percutaneous Approach

3E013VJIntroduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach

3E02305Introduction of Other Antineoplastic into Muscle, Percutaneous Approach

3E0230MIntroduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach

3E02328Introduction of Oxazolidinones into Muscle, Percutaneous Approach

3E02329Introduction of Other Anti-infective into Muscle, Percutaneous Approach

3E0233ZIntroduction of Anti-inflammatory into Muscle, Percutaneous Approach

3E02340Introduction of Influenza Vaccine into Muscle, Percutaneous Approach

3E0234ZIntroduction of Serum, Toxoid and Vaccine into Muscle, Percutaneous Approach

3E0236ZIntroduction of Nutritional Substance into Muscle, Percutaneous Approach

3E0237ZIntroduction of Electrolytic and Water Balance Substance into Muscle, Percutaneous Approach

3E023BZIntroduction of Anesthetic Agent into Muscle, Percutaneous Approach

3E023GCIntroduction of Other Therapeutic Substance into Muscle, Percutaneous Approach

3E023HZIntroduction of Radioactive Substance into Muscle, Percutaneous Approach

3E023KZIntroduction of Other Diagnostic Substance into Muscle, Percutaneous Approach

3E023NZIntroduction of Analgesics, Hypnotics, Sedatives into Muscle, Percutaneous Approach

3E023TZIntroduction of Destructive Agent into Muscle, Percutaneous Approach

3E03002Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach

3E03003Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach

3E03005Introduction of Other Antineoplastic into Peripheral Vein, Open Approach

3E0300MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach

3E0300PIntroduction of Clofarabine into Peripheral Vein, Open Approach

3E03016Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Open

3E03017Introduction of Other Thrombolytic into Peripheral Vein, Open Approach

3E03028Introduction of Oxazolidinones into Peripheral Vein, Open Approach

3E03029Introduction of Other Anti-infective into Peripheral Vein, Open Approach

3E0303ZIntroduction of Anti-inflammatory into Peripheral Vein, Open Approach

3E0304ZIntroduction of Serum, Toxoid and Vaccine into Peripheral Vein, Open Approach

3E0306ZIntroduction of Nutritional Substance into Peripheral Vein, Open Approach

3E0307ZIntroduction of Electrolytic and Water Balance Substance into Peripheral Vein, Open Approach

3E030FZIntroduction of Intracirculatory Anesthetic into Peripheral Vein, Open Approach

3E030GCIntroduction of Other Therapeutic Substance into Peripheral Vein, Open Approach

3E030GNIntroduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Open Approach

3E030HZIntroduction of Radioactive Substance into Peripheral Vein, Open Approach

3E030KZIntroduction of Other Diagnostic Substance into Peripheral Vein, Open Approach

3E030NZIntroduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Open Approach

3E030PZIntroduction of Platelet Inhibitor into Peripheral Vein, Open Approach

3E030RZIntroduction of Antiarrhythmic into Peripheral Vein, Open Approach

3E030TZIntroduction of Destructive Agent into Peripheral Vein, Open Approach

3E030U0Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Open Approach

3E030U1Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Open Approach

3E030VGIntroduction of Insulin into Peripheral Vein, Open Approach

3E030VHIntroduction of Human B-type Natriuretic Peptide into Peripheral Vein, Open Approach

3E030VJIntroduction of Other Hormone into Peripheral Vein, Open Approach

3E030WKIntroduction of Immunostimulator into Peripheral Vein, Open

3E030WLIntroduction of Immunosuppressive into Peripheral Vein, Open

3E030XZIntroduction of Vasopressor into Peripheral Vein, Open Approach

3E03302Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach

3E03303Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach

3E03305Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach

3E0330MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach

3E0330PIntroduction of Clofarabine into Peripheral Vein, Percutaneous Approach

3E03316Introduction of Recombinant Human-activated Protein C into Peripheral Vein, Percutaneous

3E03317Introduction of Other Thrombolytic into Peripheral Vein, Percutaneous Approach

3E03328Introduction of Oxazolidinones into Peripheral Vein, Percutaneous Approach

3E03329Introduction of Other Anti-infective into Peripheral Vein, Percutaneous Approach

3E0333ZIntroduction of Anti-inflammatory into Peripheral Vein, Percutaneous Approach

3E0334ZIntroduction of Serum, Toxoid and Vaccine into Peripheral Vein, Percutaneous Approach

3E0336ZIntroduction of Nutritional Substance into Peripheral Vein, Percutaneous Approach

3E0337ZIntroduction of Electrolytic and Water Balance Substance into Peripheral Vein, Percutaneous Approach

3E033FZIntroduction of Intracirculatory Anesthetic into Peripheral Vein, Percutaneous Approach

3E033GCIntroduction of Other Therapeutic Substance into Peripheral Vein, Percutaneous Approach

3E033GNIntroduction of Blood Brain Barrier Disruption Substance into Peripheral Vein, Percutaneous Approach

3E033GQIntroduction of Glucarpidase into Peripheral Vein, Percutaneous Approach

3E033GRIntroduction of Other Therapeutic Monoclonal Antibody into Peripheral Vein, Percutaneous Approach

3E033HZIntroduction of Radioactive Substance into Peripheral Vein, Percutaneous Approach

3E033KZIntroduction of Other Diagnostic Substance into Peripheral Vein, Percutaneous Approach

3E033NZIntroduction of Analgesics, Hypnotics, Sedatives into Peripheral Vein, Percutaneous Approach

3E033PZIntroduction of Platelet Inhibitor into Peripheral Vein, Percutaneous Approach

3E033RZIntroduction of Antiarrhythmic into Peripheral Vein, Percutaneous Approach

3E033TZIntroduction of Destructive Agent into Peripheral Vein, Percutaneous Approach

3E033U0Introduction of Autologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach

3E033U1Introduction of Nonautologous Pancreatic Islet Cells into Peripheral Vein, Percutaneous Approach

3E033VGIntroduction of Insulin into Peripheral Vein, Percutaneous Approach

3E033VHIntroduction of Human B-type Natriuretic Peptide into Peripheral Vein, Percutaneous Approach

3E033VJIntroduction of Other Hormone into Peripheral Vein, Percutaneous Approach

3E033WKIntroduction of Immunostimulator into Peripheral Vein, Percutaneous

3E033WLIntroduction of Immunosuppressive into Peripheral Vein, Percutaneous

3E033XZIntroduction of Vasopressor into Peripheral Vein, Percutaneous Approach

3E04002Introduction of High-dose Interleukin-2 into Central Vein, Open Approach

3E04003Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach

3E04005Introduction of Other Antineoplastic into Central Vein, Open Approach

3E0400MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach

3E0400PIntroduction of Clofarabine into Central Vein, Open Approach

3E04016Introduction of Recombinant Human-activated Protein C into Central Vein, Open

3E04017Introduction of Other Thrombolytic into Central Vein, Open Approach

3E04028Introduction of Oxazolidinones into Central Vein, Open Approach

3E04029Introduction of Other Anti-infective into Central Vein, Open Approach

3E0403ZIntroduction of Anti-inflammatory into Central Vein, Open Approach

3E0404ZIntroduction of Serum, Toxoid and Vaccine into Central Vein, Open Approach

3E0406ZIntroduction of Nutritional Substance into Central Vein, Open Approach

3E0407ZIntroduction of Electrolytic and Water Balance Substance into Central Vein, Open Approach

3E040FZIntroduction of Intracirculatory Anesthetic into Central Vein, Open Approach

3E040GCIntroduction of Other Therapeutic Substance into Central Vein, Open Approach

3E040GNIntroduction of Blood Brain Barrier Disruption Substance into Central Vein, Open Approach

3E040HZIntroduction of Radioactive Substance into Central Vein, Open Approach

3E040KZIntroduction of Other Diagnostic Substance into Central Vein, Open Approach

3E040NZIntroduction of Analgesics, Hypnotics, Sedatives into Central Vein, Open Approach

3E040PZIntroduction of Platelet Inhibitor into Central Vein, Open Approach

3E040RZIntroduction of Antiarrhythmic into Central Vein, Open Approach

3E040TZIntroduction of Destructive Agent into Central Vein, Open Approach

3E040VGIntroduction of Insulin into Central Vein, Open Approach

3E040VHIntroduction of Human B-type Natriuretic Peptide into Central Vein, Open Approach

3E040VJIntroduction of Other Hormone into Central Vein, Open Approach

3E040WKIntroduction of Immunostimulator into Central Vein, Open

3E040WLIntroduction of Immunosuppressive into Central Vein, Open

3E040XZIntroduction of Vasopressor into Central Vein, Open Approach

3E04302Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach

3E04303Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach

3E04305Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach

3E0430MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach

3E0430PIntroduction of Clofarabine into Central Vein, Percutaneous Approach

3E04316Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous

3E04317Introduction of Other Thrombolytic into Central Vein, Percutaneous Approach

3E04328Introduction of Oxazolidinones into Central Vein, Percutaneous Approach

3E04329Introduction of Other Anti-infective into Central Vein, Percutaneous Approach

3E0433ZIntroduction of Anti-inflammatory into Central Vein, Percutaneous Approach

3E0434ZIntroduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach

3E0436ZIntroduction of Nutritional Substance into Central Vein, Percutaneous Approach

3E0437ZIntroduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach

3E043FZIntroduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach

3E043GCIntroduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach

3E043GNIntroduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach

3E043GQIntroduction of Glucarpidase into Central Vein, Percutaneous Approach

3E043GRIntroduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach

3E043HZIntroduction of Radioactive Substance into Central Vein, Percutaneous Approach

3E043KZIntroduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach

3E043NZIntroduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach

3E043PZIntroduction of Platelet Inhibitor into Central Vein, Percutaneous Approach

3E043RZIntroduction of Antiarrhythmic into Central Vein, Percutaneous Approach

3E043TZIntroduction of Destructive Agent into Central Vein, Percutaneous Approach

3E043VGIntroduction of Insulin into Central Vein, Percutaneous Approach

3E043VHIntroduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach

3E043VJIntroduction of Other Hormone into Central Vein, Percutaneous Approach

3E043WKIntroduction of Immunostimulator into Central Vein, Percutaneous

3E043WLIntroduction of Immunosuppressive into Central Vein, Percutaneous

3E043XZIntroduction of Vasopressor into Central Vein, Percutaneous Approach

3E05002Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach

3E05003Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach

3E05005Introduction of Other Antineoplastic into Peripheral Artery, Open Approach

3E0500MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach

3E0500PIntroduction of Clofarabine into Peripheral Artery, Open Approach

3E05016Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open

3E05017Introduction of Other Thrombolytic into Peripheral Artery, Open Approach

3E05028Introduction of Oxazolidinones into Peripheral Artery, Open Approach

3E05029Introduction of Other Anti-infective into Peripheral Artery, Open Approach

3E0503ZIntroduction of Anti-inflammatory into Peripheral Artery, Open Approach

3E0504ZIntroduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach

3E0506ZIntroduction of Nutritional Substance into Peripheral Artery, Open Approach

3E0507ZIntroduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach

3E050FZIntroduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach

3E050GCIntroduction of Other Therapeutic Substance into Peripheral Artery, Open Approach

3E050GNIntroduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach

3E050HZIntroduction of Radioactive Substance into Peripheral Artery, Open Approach

3E050KZIntroduction of Other Diagnostic Substance into Peripheral Artery, Open Approach

3E050NZIntroduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach

3E050PZIntroduction of Platelet Inhibitor into Peripheral Artery, Open Approach

3E050RZIntroduction of Antiarrhythmic into Peripheral Artery, Open Approach

3E050TZIntroduction of Destructive Agent into Peripheral Artery, Open Approach

3E050VGIntroduction of Insulin into Peripheral Artery, Open Approach

3E050VHIntroduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach

3E050VJIntroduction of Other Hormone into Peripheral Artery, Open Approach

3E050WKIntroduction of Immunostimulator into Peripheral Artery, Open

3E050WLIntroduction of Immunosuppressive into Peripheral Artery, Open

3E050XZIntroduction of Vasopressor into Peripheral Artery, Open Approach

3E05302Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach

3E05303Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach

3E05305Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach

3E0530MIntroduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach

3E0530PIntroduction of Clofarabine into Peripheral Artery, Percutaneous Approach

3E05316Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous

3E05317Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach

3E05328Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach

3E05329Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach

3E0533ZIntroduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach

3E0534ZIntroduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach

3E0536ZIntroduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach

3E0537ZIntroduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach

3E053FZIntroduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach

3E053GCIntroduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach

3E053GNIntroduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach

3E053HZIntroduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach

3E053KZIntroduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach

3E053NZIntroduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach

3E053PZIntroduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach

3E053RZIntroduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach

3E053TZIntroduction of Destructive Agent into Peripheral Artery, Percutaneous Approach

3E053VGIntroduction of Insulin into Peripheral Artery, Percutaneous Approach

3E053VHIntroduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach

3E053VJIntroduction of Other Hormone into Peripheral Artery, Percutaneous Approach

3E053WKIntroduction of Immunostimulator into Peripheral Artery, Percutaneous

3E053WLIntroduction of Immunosuppressive into Peripheral Artery, Percutaneous

3E053XZIntroduction of Vasopressor into Peripheral Artery, Percutaneous Approach

3E06002Introduction of High-dose Interleukin-2 into Central Artery, Open Approach

3E06003Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach

3E06005Introduction of Other Antineoplastic into Central Artery, Open Approach

3E0600MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach

3E0600PIntroduction of Clofarabine into Central Artery, Open Approach

3E06016Introduction of Recombinant Human-activated Protein C into Central Artery, Open

3E06017Introduction of Other Thrombolytic into Central Artery, Open Approach

3E06028Introduction of Oxazolidinones into Central Artery, Open Approach

3E06029Introduction of Other Anti-infective into Central Artery, Open Approach

3E0603ZIntroduction of Anti-inflammatory into Central Artery, Open Approach

3E0604ZIntroduction of Serum, Toxoid and Vaccine into Central Artery, Open Approach

3E0606ZIntroduction of Nutritional Substance into Central Artery, Open Approach

3E0607ZIntroduction of Electrolytic and Water Balance Substance into Central Artery, Open Approach

3E060FZIntroduction of Intracirculatory Anesthetic into Central Artery, Open Approach

3E060GCIntroduction of Other Therapeutic Substance into Central Artery, Open Approach

3E060GNIntroduction of Blood Brain Barrier Disruption Substance into Central Artery, Open Approach

3E060HZIntroduction of Radioactive Substance into Central Artery, Open Approach

3E060KZIntroduction of Other Diagnostic Substance into Central Artery, Open Approach

3E060NZIntroduction of Analgesics, Hypnotics, Sedatives into Central Artery, Open Approach

3E060PZIntroduction of Platelet Inhibitor into Central Artery, Open Approach

3E060RZIntroduction of Antiarrhythmic into Central Artery, Open Approach

3E060TZIntroduction of Destructive Agent into Central Artery, Open Approach

3E060VGIntroduction of Insulin into Central Artery, Open Approach

3E060VHIntroduction of Human B-type Natriuretic Peptide into Central Artery, Open Approach

3E060VJIntroduction of Other Hormone into Central Artery, Open Approach

3E060WKIntroduction of Immunostimulator into Central Artery, Open

3E060WLIntroduction of Immunosuppressive into Central Artery, Open

3E060XZIntroduction of Vasopressor into Central Artery, Open Approach

3E06302Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach

3E06303Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach

3E06305Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach

3E0630MIntroduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach

3E0630PIntroduction of Clofarabine into Central Artery, Percutaneous Approach

3E06316Introduction of Recombinant Human-activated Protein C into Central Artery, Percutaneous

3E06317Introduction of Other Thrombolytic into Central Artery, Percutaneous Approach

3E06328Introduction of Oxazolidinones into Central Artery, Percutaneous Approach

3E06329Introduction of Other Anti-infective into Central Artery, Percutaneous Approach

3E0633ZIntroduction of Anti-inflammatory into Central Artery, Percutaneous Approach

3E0634ZIntroduction of Serum, Toxoid and Vaccine into Central Artery, Percutaneous Approach

3E0636ZIntroduction of Nutritional Substance into Central Artery, Percutaneous Approach

3E0637ZIntroduction of Electrolytic and Water Balance Substance into Central Artery, Percutaneous Approach

3E063FZIntroduction of Intracirculatory Anesthetic into Central Artery, Percutaneous Approach

3E063GCIntroduction of Other Therapeutic Substance into Central Artery, Percutaneous Approach

3E063GNIntroduction of Blood Brain Barrier Disruption Substance into Central Artery, Percutaneous Approach

3E063HZIntroduction of Radioactive Substance into Central Artery, Percutaneous Approach

3E063KZIntroduction of Other Diagnostic Substance into Central Artery, Percutaneous Approach

3E063NZIntroduction of Analgesics, Hypnotics, Sedatives into Central Artery, Percutaneous Approach

3E063PZIntroduction of Platelet Inhibitor into Central Artery, Percutaneous Approach

3E063RZIntroduction of Antiarrhythmic into Central Artery, Percutaneous Approach

3E063TZIntroduction of Destructive Agent into Central Artery, Percutaneous Approach

3E063VGIntroduction of Insulin into Central Artery, Percutaneous Approach

3E063VHIntroduction of Human B-type Natriuretic Peptide into Central Artery, Percutaneous Approach

3E063VJIntroduction of Other Hormone into Central Artery, Percutaneous Approach

3E063WKIntroduction of Immunostimulator into Central Artery, Percutaneous

3E063WLIntroduction of Immunosuppressive into Central Artery, Percutaneous

3E063XZIntroduction of Vasopressor into Central Artery, Percutaneous Approach

3E07016Introduction of Recombinant Human-activated Protein C into Coronary Artery, Open

3E07017Introduction of Other Thrombolytic into Coronary Artery, Open Approach

3E070GCIntroduction of Other Therapeutic Substance into Coronary Artery, Open Approach

3E070KZIntroduction of Other Diagnostic Substance into Coronary Artery, Open Approach

3E070PZIntroduction of Platelet Inhibitor into Coronary Artery, Open Approach

3E07316Introduction of Recombinant Human-activated Protein C into Coronary Artery, Percutaneous

3E07317Introduction of Other Thrombolytic into Coronary Artery, Percutaneous Approach

3E073GCIntroduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Approach

3E073KZIntroduction of Other Diagnostic Substance into Coronary Artery, Percutaneous Approach

3E073PZIntroduction of Platelet Inhibitor into Coronary Artery, Percutaneous Approach

3E074GCIntroduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Endoscopic Approach

3E08016Introduction of Recombinant Human-activated Protein C into Heart, Open

3E08017Introduction of Other Thrombolytic into Heart, Open Approach

3E080GCIntroduction of Other Therapeutic Substance into Heart, Open Approach

3E080KZIntroduction of Other Diagnostic Substance into Heart, Open Approach

3E080PZIntroduction of Platelet Inhibitor into Heart, Open Approach

3E08316Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous

3E08317Introduction of Other Thrombolytic into Heart, Percutaneous Approach

3E083GCIntroduction of Other Therapeutic Substance into Heart, Percutaneous Approach

3E083KZIntroduction of Other Diagnostic Substance into Heart, Percutaneous Approach

3E083PZIntroduction of Platelet Inhibitor into Heart, Percutaneous Approach

3E084GCIntroduction of Other Therapeutic Substance into Heart, Percutaneous Endoscopic Approach

3E09305Introduction of Other Antineoplastic into Nose, Percutaneous Approach

3E0930MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach

3E09328Introduction of Oxazolidinones into Nose, Percutaneous Approach

3E09329Introduction of Other Anti-infective into Nose, Percutaneous Approach

3E0933ZIntroduction of Anti-inflammatory into Nose, Percutaneous Approach

3E0934ZIntroduction of Serum, Toxoid and Vaccine into Nose, Percutaneous Approach

3E093BZIntroduction of Anesthetic Agent into Nose, Percutaneous Approach

3E093GCIntroduction of Other Therapeutic Substance into Nose, Percutaneous Approach

3E093HZIntroduction of Radioactive Substance into Nose, Percutaneous Approach

3E093KZIntroduction of Other Diagnostic Substance into Nose, Percutaneous Approach

3E093NZIntroduction of Analgesics, Hypnotics, Sedatives into Nose, Percutaneous Approach

3E093TZIntroduction of Destructive Agent into Nose, Percutaneous Approach

3E09705Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening

3E0970MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening

3E09728Introduction of Oxazolidinones into Nose, Via Natural or Artificial Opening

3E09729Introduction of Other Anti-infective into Nose, Via Natural or Artificial Opening

3E0973ZIntroduction of Anti-inflammatory into Nose, Via Natural or Artificial Opening

3E0974ZIntroduction of Serum, Toxoid and Vaccine into Nose, Via Natural or Artificial Opening

3E097BZIntroduction of Anesthetic Agent into Nose, Via Natural or Artificial Opening

3E097GCIntroduction of Other Therapeutic Substance into Nose, Via Natural or Artificial Opening

3E097HZIntroduction of Radioactive Substance into Nose, Via Natural or Artificial Opening

3E097KZIntroduction of Other Diagnostic Substance into Nose, Via Natural or Artificial Opening

3E097NZIntroduction of Analgesics, Hypnotics, Sedatives into Nose, Via Natural or Artificial Opening

3E097TZIntroduction of Destructive Agent into Nose, Via Natural or Artificial Opening

3E09X05Introduction of Other Antineoplastic into Nose, External Approach

3E09X0MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach

3E09X28Introduction of Oxazolidinones into Nose, External Approach

3E09X29Introduction of Other Anti-infective into Nose, External Approach

3E09X3ZIntroduction of Anti-inflammatory into Nose, External Approach

3E09X4ZIntroduction of Serum, Toxoid and Vaccine into Nose, External Approach

3E09XBZIntroduction of Anesthetic Agent into Nose, External Approach

3E09XGCIntroduction of Other Therapeutic Substance into Nose, External Approach

3E09XHZIntroduction of Radioactive Substance into Nose, External Approach

3E09XKZIntroduction of Other Diagnostic Substance into Nose, External Approach

3E09XNZIntroduction of Analgesics, Hypnotics, Sedatives into Nose, External Approach

3E09XTZIntroduction of Destructive Agent into Nose, External Approach

3E0A305Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach

3E0A30MIntroduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach

3E0A3GCIntroduction of Other Therapeutic Substance into Bone Marrow, Percutaneous Approach

3E0B304Introduction of Liquid Brachytherapy Radioisotope into Ear, Percutaneous Approach

3E0B305Introduction of Other Antineoplastic into Ear, Percutaneous Approach

3E0B30MIntroduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach

3E0B328Introduction of Oxazolidinones into Ear, Percutaneous Approach

3E0B329Introduction of Other Anti-infective into Ear, Percutaneous Approach

3E0B33ZIntroduction of Anti-inflammatory into Ear, Percutaneous Approach

3E0B3BZIntroduction of Anesthetic Agent into Ear, Percutaneous Approach

3E0B3GCIntroduction of Other Therapeutic Substance into Ear, Percutaneous Approach

3E0B3HZIntroduction of Radioactive Substance into Ear, Percutaneous Approach

3E0B3KZIntroduction of Other Diagnostic Substance into Ear, Percutaneous Approach

3E0B3NZIntroduction of Analgesics, Hypnotics, Sedatives into Ear, Percutaneous Approach

3E0B3TZIntroduction of Destructive Agent into Ear, Percutaneous Approach

3E0B704Introduction of Liquid Brachytherapy Radioisotope into Ear, Via Natural or Artificial Opening

3E0B705Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening

3E0B70MIntroduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening

3E0B728Introduction of Oxazolidinones into Ear, Via Natural or Artificial Opening

3E0B729Introduction of Other Anti-infective into Ear, Via Natural or Artificial Opening

3E0B73ZIntroduction of Anti-inflammatory into Ear, Via Natural or Artificial Opening

3E0B7BZIntroduction of Anesthetic Agent into Ear, Via Natural or Artificial Opening

3E0B7GCIntroduction of Other Therapeutic Substance into Ear, Via Natural or Artificial Opening

3E0B7HZIntroduction of Radioactive Substance into Ear, Via Natural or Artificial Opening

3E0B7KZIntroduction of Other Diagnostic Substance into Ear, Via Natural or Artificial Opening

3E0B7NZIntroduction of Analgesics, Hypnotics, Sedatives into Ear, Via Natural or Artificial Opening

3E0B7TZIntroduction of Destructive Agent into Ear, Via Natural or Artificial Opening

3E0BX04Introduction of Liquid Brachytherapy Radioisotope into Ear, External Approach

3E0BX05Introduction of Other Antineoplastic into Ear, External Approach

3E0BX0MIntroduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach

3E0BX28Introduction of Oxazolidinones into Ear, External Approach

3E0BX29Introduction of Other Anti-infective into Ear, External Approach

3E0BX3ZIntroduction of Anti-inflammatory into Ear, External Approach

3E0BXBZIntroduction of Anesthetic Agent into Ear, External Approach

3E0BXGCIntroduction of Other Therapeutic Substance into Ear, External Approach

3E0BXHZIntroduction of Radioactive Substance into Ear, External Approach

3E0BXKZIntroduction of Other Diagnostic Substance into Ear, External Approach

3E0BXNZIntroduction of Analgesics, Hypnotics, Sedatives into Ear, External Approach

3E0BXTZIntroduction of Destructive Agent into Ear, External Approach

3E0C304Introduction of Liquid Brachytherapy Radioisotope into Eye, Percutaneous Approach

3E0C305Introduction of Other Antineoplastic into Eye, Percutaneous Approach

3E0C30MIntroduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach

3E0C328Introduction of Oxazolidinones into Eye, Percutaneous Approach

3E0C329Introduction of Other Anti-infective into Eye, Percutaneous Approach

3E0C33ZIntroduction of Anti-inflammatory into Eye, Percutaneous Approach

3E0C3BZIntroduction of Anesthetic Agent into Eye, Percutaneous Approach

3E0C3GCIntroduction of Other Therapeutic Substance into Eye, Percutaneous Approach

3E0C3HZIntroduction of Radioactive Substance into Eye, Percutaneous Approach

3E0C3KZIntroduction of Other Diagnostic Substance into Eye, Percutaneous Approach

3E0C3MZIntroduction of Pigment into Eye, Percutaneous Approach

3E0C3NZIntroduction of Analgesics, Hypnotics, Sedatives into Eye, Percutaneous Approach

3E0C3SFIntroduction of Other Gas into Eye, Percutaneous Approach

3E0C3TZIntroduction of Destructive Agent into Eye, Percutaneous Approach

3E0C704Introduction of Liquid Brachytherapy Radioisotope into Eye, Via Natural or Artificial Opening

3E0C705Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening

3E0C70MIntroduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening

3E0C728Introduction of Oxazolidinones into Eye, Via Natural or Artificial Opening

3E0C729Introduction of Other Anti-infective into Eye, Via Natural or Artificial Opening

3E0C73ZIntroduction of Anti-inflammatory into Eye, Via Natural or Artificial Opening

3E0C7BZIntroduction of Anesthetic Agent into Eye, Via Natural or Artificial Opening

3E0C7GCIntroduction of Other Therapeutic Substance into Eye, Via Natural or Artificial Opening

3E0C7HZIntroduction of Radioactive Substance into Eye, Via Natural or Artificial Opening

3E0C7KZIntroduction of Other Diagnostic Substance into Eye, Via Natural or Artificial Opening

3E0C7MZIntroduction of Pigment into Eye, Via Natural or Artificial Opening

3E0C7NZIntroduction of Analgesics, Hypnotics, Sedatives into Eye, Via Natural or Artificial Opening

3E0C7SFIntroduction of Other Gas into Eye, Via Natural or Artificial Opening

3E0C7TZIntroduction of Destructive Agent into Eye, Via Natural or Artificial Opening

3E0CX04Introduction of Liquid Brachytherapy Radioisotope into Eye, External Approach

3E0CX05Introduction of Other Antineoplastic into Eye, External Approach

3E0CX0MIntroduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach

3E0CX28Introduction of Oxazolidinones into Eye, External Approach

3E0CX29Introduction of Other Anti-infective into Eye, External Approach

3E0CX3ZIntroduction of Anti-inflammatory into Eye, External Approach

3E0CXBZIntroduction of Anesthetic Agent into Eye, External Approach

3E0CXGCIntroduction of Other Therapeutic Substance into Eye, External Approach

3E0CXHZIntroduction of Radioactive Substance into Eye, External Approach

3E0CXKZIntroduction of Other Diagnostic Substance into Eye, External Approach

3E0CXMZIntroduction of Pigment into Eye, External Approach

3E0CXNZIntroduction of Analgesics, Hypnotics, Sedatives into Eye, External Approach

3E0CXSFIntroduction of Other Gas into Eye, External Approach

3E0CXTZIntroduction of Destructive Agent into Eye, External Approach

3E0D304Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Percutaneous Approach

3E0D305Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach

3E0D30MIntroduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach

3E0D328Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach

3E0D329Introduction of Other Anti-infective into Mouth and Pharynx, Percutaneous Approach

3E0D33ZIntroduction of Anti-inflammatory into Mouth and Pharynx, Percutaneous Approach

3E0D34ZIntroduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Percutaneous Approach

3E0D36ZIntroduction of Nutritional Substance into Mouth and Pharynx, Percutaneous Approach

3E0D37ZIntroduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Percutaneous Approach

3E0D3BZIntroduction of Anesthetic Agent into Mouth and Pharynx, Percutaneous Approach

3E0D3GCIntroduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approach

3E0D3HZIntroduction of Radioactive Substance into Mouth and Pharynx, Percutaneous Approach

3E0D3KZIntroduction of Other Diagnostic Substance into Mouth and Pharynx, Percutaneous Approach

3E0D3NZIntroduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Percutaneous Approach

3E0D3RZIntroduction of Antiarrhythmic into Mouth and Pharynx, Percutaneous Approach

3E0D3TZIntroduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approach

3E0D704Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D705Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D70MIntroduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D728Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D729Introduction of Other Anti-infective into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D73ZIntroduction of Anti-inflammatory into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D74ZIntroduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D76ZIntroduction of Nutritional Substance into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D77ZIntroduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D7BZIntroduction of Anesthetic Agent into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D7GCIntroduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D7HZIntroduction of Radioactive Substance into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D7KZIntroduction of Other Diagnostic Substance into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D7NZIntroduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D7RZIntroduction of Antiarrhythmic into Mouth and Pharynx, Via Natural or Artificial Opening

3E0D7TZIntroduction of Destructive Agent into Mouth and Pharynx, Via Natural or Artificial Opening

3E0DX04Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, External Approach

3E0DX05Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach

3E0DX0MIntroduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach

3E0DX28Introduction of Oxazolidinones into Mouth and Pharynx, External Approach

3E0DX29Introduction of Other Anti-infective into Mouth and Pharynx, External Approach

3E0DX3ZIntroduction of Anti-inflammatory into Mouth and Pharynx, External Approach

3E0DX4ZIntroduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, External Approach

3E0DX6ZIntroduction of Nutritional Substance into Mouth and Pharynx, External Approach

3E0DX7ZIntroduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, External Approach

3E0DXBZIntroduction of Anesthetic Agent into Mouth and Pharynx, External Approach

3E0DXGCIntroduction of Other Therapeutic Substance into Mouth and Pharynx, External Approach

3E0DXHZIntroduction of Radioactive Substance into Mouth and Pharynx, External Approach

3E0DXKZIntroduction of Other Diagnostic Substance into Mouth and Pharynx, External Approach

3E0DXNZIntroduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, External Approach

3E0DXRZIntroduction of Antiarrhythmic into Mouth and Pharynx, External Approach

3E0DXTZIntroduction of Destructive Agent into Mouth and Pharynx, External Approach

3E0E304Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach

3E0E305Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach

3E0E30MIntroduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach

3E0E328Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach

3E0E329Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach

3E0E33ZIntroduction of Anti-inflammatory into Products of Conception, Percutaneous Approach

3E0E36ZIntroduction of Nutritional Substance into Products of Conception, Percutaneous Approach

3E0E37ZIntroduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach

3E0E3BZIntroduction of Anesthetic Agent into Products of Conception, Percutaneous Approach

3E0E3GCIntroduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach

3E0E3HZIntroduction of Radioactive Substance into Products of Conception, Percutaneous Approach

3E0E3KZIntroduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach

3E0E3NZIntroduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach

3E0E3SFIntroduction of Other Gas into Products of Conception, Percutaneous Approach

3E0E3TZIntroduction of Destructive Agent into Products of Conception, Percutaneous Approach

3E0E4GCIntroduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach

3E0E704Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening

3E0E705Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening

3E0E70MIntroduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening

3E0E728Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening

3E0E729Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening

3E0E73ZIntroduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening

3E0E76ZIntroduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening

3E0E77ZIntroduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening

3E0E7BZIntroduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening

3E0E7GCIntroduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening

3E0E7HZIntroduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening

3E0E7KZIntroduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening

3E0E7NZIntroduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening

3E0E7SFIntroduction of Other Gas into Products of Conception, Via Natural or Artificial Opening

3E0E7TZIntroduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening

3E0E804Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E805Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E80MIntroduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E828Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E829Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E83ZIntroduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E86ZIntroduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E87ZIntroduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E8BZIntroduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E8GCIntroduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E8HZIntroduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E8KZIntroduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E8NZIntroduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E8SFIntroduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0E8TZIntroduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic

3E0F304Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Percutaneous Approach

3E0F305Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach

3E0F30MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach

3E0F328Introduction of Oxazolidinones into Respiratory Tract, Percutaneous Approach

3E0F329Introduction of Other Anti-infective into Respiratory Tract, Percutaneous Approach

3E0F33ZIntroduction of Anti-inflammatory into Respiratory Tract, Percutaneous Approach

3E0F36ZIntroduction of Nutritional Substance into Respiratory Tract, Percutaneous Approach

3E0F37ZIntroduction of Electrolytic and Water Balance Substance into Respiratory Tract, Percutaneous Approach

3E0F3BZIntroduction of Anesthetic Agent into Respiratory Tract, Percutaneous Approach

3E0F3GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Approach

3E0F3HZIntroduction of Radioactive Substance into Respiratory Tract, Percutaneous Approach

3E0F3KZIntroduction of Other Diagnostic Substance into Respiratory Tract, Percutaneous Approach

3E0F3NZIntroduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Percutaneous Approach

3E0F3SDIntroduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach

3E0F3SFIntroduction of Other Gas into Respiratory Tract, Percutaneous Approach

3E0F3TZIntroduction of Destructive Agent into Respiratory Tract, Percutaneous Approach

3E0F4GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Percutaneous Endoscopic Approach

3E0F704Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening

3E0F705Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening

3E0F70MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening

3E0F728Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening

3E0F729Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening

3E0F73ZIntroduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening

3E0F76ZIntroduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening

3E0F77ZIntroduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening

3E0F7BZIntroduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening

3E0F7GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening

3E0F7HZIntroduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening

3E0F7KZIntroduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening

3E0F7NZIntroduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening

3E0F7SDIntroduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening

3E0F7SFIntroduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening

3E0F7TZIntroduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening

3E0F804Introduction of Liquid Brachytherapy Radioisotope into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F805Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F80MIntroduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F828Introduction of Oxazolidinones into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F829Introduction of Other Anti-infective into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F83ZIntroduction of Anti-inflammatory into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F86ZIntroduction of Nutritional Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F87ZIntroduction of Electrolytic and Water Balance Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8BZIntroduction of Anesthetic Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8GCIntroduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8HZIntroduction of Radioactive Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8KZIntroduction of Other Diagnostic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8NZIntroduction of Analgesics, Hypnotics, Sedatives into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8SDIntroduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8SFIntroduction of Other Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0F8TZIntroduction of Destructive Agent into Respiratory Tract, Via Natural or Artificial Opening Endoscopic

3E0G304Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Percutaneous Approach

3E0G305Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach

3E0G30MIntroduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach

3E0G328Introduction of Oxazolidinones into Upper GI, Percutaneous Approach

3E0G329Introduction of Other Anti-infective into Upper GI, Percutaneous Approach

3E0G33ZIntroduction of Anti-inflammatory into Upper GI, Percutaneous Approach

3E0G36ZIntroduction of Nutritional Substance into Upper GI, Percutaneous Approach

3E0G37ZIntroduction of Electrolytic and Water Balance Substance into Upper GI, Percutaneous Approach

3E0G3BZIntroduction of Anesthetic Agent into Upper GI, Percutaneous Approach

3E0G3GCIntroduction of Other Therapeutic Substance into Upper GI, Percutaneous Approach

3E0G3HZIntroduction of Radioactive Substance into Upper GI, Percutaneous Approach

3E0G3KZIntroduction of Other Diagnostic Substance into Upper GI, Percutaneous Approach

3E0G3NZIntroduction of Analgesics, Hypnotics, Sedatives into Upper GI, Percutaneous Approach

3E0G3SFIntroduction of Other Gas into Upper GI, Percutaneous Approach

3E0G3TZIntroduction of Destructive Agent into Upper GI, Percutaneous Approach

3E0G4GCIntroduction of Other Therapeutic Substance into Upper GI, Percutaneous Endoscopic Approach

3E0G704Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening

3E0G705Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening

3E0G70MIntroduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening

3E0G728Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening

3E0G729Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening

3E0G73ZIntroduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening

3E0G76ZIntroduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening

3E0G77ZIntroduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening

3E0G7BZIntroduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening

3E0G7GCIntroduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening

3E0G7HZIntroduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening

3E0G7KZIntroduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening

3E0G7NZIntroduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening

3E0G7SFIntroduction of Other Gas into Upper GI, Via Natural or Artificial Opening

3E0G7TZIntroduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening

3E0G804Introduction of Liquid Brachytherapy Radioisotope into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G805Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G80MIntroduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G828Introduction of Oxazolidinones into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G829Introduction of Other Anti-infective into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G83ZIntroduction of Anti-inflammatory into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G86ZIntroduction of Nutritional Substance into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G87ZIntroduction of Electrolytic and Water Balance Substance into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G8BZIntroduction of Anesthetic Agent into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G8GCIntroduction of Other Therapeutic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G8HZIntroduction of Radioactive Substance into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G8KZIntroduction of Other Diagnostic Substance into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G8NZIntroduction of Analgesics, Hypnotics, Sedatives into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G8SFIntroduction of Other Gas into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0G8TZIntroduction of Destructive Agent into Upper GI, Via Natural or Artificial Opening Endoscopic

3E0H304Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Percutaneous Approach

3E0H305Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach

3E0H30MIntroduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach

3E0H328Introduction of Oxazolidinones into Lower GI, Percutaneous Approach

3E0H329Introduction of Other Anti-infective into Lower GI, Percutaneous Approach

3E0H33ZIntroduction of Anti-inflammatory into Lower GI, Percutaneous Approach

3E0H36ZIntroduction of Nutritional Substance into Lower GI, Percutaneous Approach

3E0H37ZIntroduction of Electrolytic and Water Balance Substance into Lower GI, Percutaneous Approach

3E0H3BZIntroduction of Anesthetic Agent into Lower GI, Percutaneous Approach

3E0H3GCIntroduction of Other Therapeutic Substance into Lower GI, Percutaneous Approach

3E0H3HZIntroduction of Radioactive Substance into Lower GI, Percutaneous Approach

3E0H3KZIntroduction of Other Diagnostic Substance into Lower GI, Percutaneous Approach

3E0H3NZIntroduction of Analgesics, Hypnotics, Sedatives into Lower GI, Percutaneous Approach

3E0H3SFIntroduction of Other Gas into Lower GI, Percutaneous Approach

3E0H3TZIntroduction of Destructive Agent into Lower GI, Percutaneous Approach

3E0H4GCIntroduction of Other Therapeutic Substance into Lower GI, Percutaneous Endoscopic Approach

3E0H704Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening

3E0H705Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening

3E0H70MIntroduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening

3E0H728Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening

3E0H729Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening

3E0H73ZIntroduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening

3E0H76ZIntroduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening

3E0H77ZIntroduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening

3E0H7BZIntroduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening

3E0H7GCIntroduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening

3E0H7HZIntroduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening

3E0H7KZIntroduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening

3E0H7NZIntroduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening

3E0H7SFIntroduction of Other Gas into Lower GI, Via Natural or Artificial Opening

3E0H7TZIntroduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening

3E0H804Introduction of Liquid Brachytherapy Radioisotope into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H805Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H80MIntroduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H828Introduction of Oxazolidinones into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H829Introduction of Other Anti-infective into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H83ZIntroduction of Anti-inflammatory into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H86ZIntroduction of Nutritional Substance into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H87ZIntroduction of Electrolytic and Water Balance Substance into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H8BZIntroduction of Anesthetic Agent into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H8GCIntroduction of Other Therapeutic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H8HZIntroduction of Radioactive Substance into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H8KZIntroduction of Other Diagnostic Substance into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H8NZIntroduction of Analgesics, Hypnotics, Sedatives into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H8SFIntroduction of Other Gas into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0H8TZIntroduction of Destructive Agent into Lower GI, Via Natural or Artificial Opening Endoscopic

3E0J304Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J305Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J30MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J328Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J329Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J33ZIntroduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J36ZIntroduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J37ZIntroduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3BZIntroduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3GCIntroduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3HZIntroduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3KZIntroduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3NZIntroduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3SFIntroduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3TZIntroduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J3U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach

3E0J4GCIntroduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach

3E0J704Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J705Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J70MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J728Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J729Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J73ZIntroduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J76ZIntroduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J77ZIntroduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7BZIntroduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7GCIntroduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7HZIntroduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7KZIntroduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7NZIntroduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7SFIntroduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7TZIntroduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J7U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening

3E0J804Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J805Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J80MIntroduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J828Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J829Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J83ZIntroduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J86ZIntroduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J87ZIntroduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8BZIntroduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8GCIntroduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8HZIntroduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8KZIntroduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8NZIntroduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8SFIntroduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8TZIntroduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8U0Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0J8U1Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic

3E0K304Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Percutaneous Approach

3E0K305Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach

3E0K30MIntroduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach

3E0K328Introduction of Oxazolidinones into Genitourinary Tract, Percutaneous Approach

3E0K329Introduction of Other Anti-infective into Genitourinary Tract, Percutaneous Approach

3E0K33ZIntroduction of Anti-inflammatory into Genitourinary Tract, Percutaneous Approach

3E0K36ZIntroduction of Nutritional Substance into Genitourinary Tract, Percutaneous Approach

3E0K37ZIntroduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Percutaneous Approach

3E0K3BZIntroduction of Anesthetic Agent into Genitourinary Tract, Percutaneous Approach

3E0K3GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Approach

3E0K3HZIntroduction of Radioactive Substance into Genitourinary Tract, Percutaneous Approach

3E0K3KZIntroduction of Other Diagnostic Substance into Genitourinary Tract, Percutaneous Approach

3E0K3NZIntroduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Percutaneous Approach

3E0K3SFIntroduction of Other Gas into Genitourinary Tract, Percutaneous Approach

3E0K3TZIntroduction of Destructive Agent into Genitourinary Tract, Percutaneous Approach

3E0K4GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Percutaneous Endoscopic Approach

3E0K704Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening

3E0K705Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening

3E0K70MIntroduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening

3E0K728Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening

3E0K729Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening

3E0K73ZIntroduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening

3E0K76ZIntroduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening

3E0K77ZIntroduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening

3E0K7BZIntroduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening

3E0K7GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening

3E0K7HZIntroduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening

3E0K7KZIntroduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening

3E0K7NZIntroduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening

3E0K7SFIntroduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening

3E0K7TZIntroduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening

3E0K804Introduction of Liquid Brachytherapy Radioisotope into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K805Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K80MIntroduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K828Introduction of Oxazolidinones into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K829Introduction of Other Anti-infective into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K83ZIntroduction of Anti-inflammatory into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K86ZIntroduction of Nutritional Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K87ZIntroduction of Electrolytic and Water Balance Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K8BZIntroduction of Anesthetic Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K8GCIntroduction of Other Therapeutic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K8HZIntroduction of Radioactive Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K8KZIntroduction of Other Diagnostic Substance into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K8NZIntroduction of Analgesics, Hypnotics, Sedatives into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K8SFIntroduction of Other Gas into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0K8TZIntroduction of Destructive Agent into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic

3E0L05ZIntroduction of Adhesion Barrier into Pleural Cavity, Open Approach

3E0L304Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Percutaneous Approach

3E0L305Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach

3E0L30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach

3E0L317Introduction of Other Thrombolytic into Pleural Cavity, Percutaneous Approach

3E0L328Introduction of Oxazolidinones into Pleural Cavity, Percutaneous Approach

3E0L329Introduction of Other Anti-infective into Pleural Cavity, Percutaneous Approach

3E0L33ZIntroduction of Anti-inflammatory into Pleural Cavity, Percutaneous Approach

3E0L35ZIntroduction of Adhesion Barrier into Pleural Cavity, Percutaneous Approach

3E0L36ZIntroduction of Nutritional Substance into Pleural Cavity, Percutaneous Approach

3E0L37ZIntroduction of Electrolytic and Water Balance Substance into Pleural Cavity, Percutaneous Approach

3E0L3BZIntroduction of Anesthetic Agent into Pleural Cavity, Percutaneous Approach

3E0L3GCIntroduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Approach

3E0L3HZIntroduction of Radioactive Substance into Pleural Cavity, Percutaneous Approach

3E0L3KZIntroduction of Other Diagnostic Substance into Pleural Cavity, Percutaneous Approach

3E0L3NZIntroduction of Analgesics, Hypnotics, Sedatives into Pleural Cavity, Percutaneous Approach

3E0L3SFIntroduction of Other Gas into Pleural Cavity, Percutaneous Approach

3E0L3TZIntroduction of Destructive Agent into Pleural Cavity, Percutaneous Approach

3E0L45ZIntroduction of Adhesion Barrier into Pleural Cavity, Percutaneous Endoscopic Approach

3E0L4GCIntroduction of Other Therapeutic Substance into Pleural Cavity, Percutaneous Endoscopic Approach

3E0L704Introduction of Liquid Brachytherapy Radioisotope into Pleural Cavity, Via Natural or Artificial Opening

3E0L705Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening

3E0L70MIntroduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening

3E0L7SFIntroduction of Other Gas into Pleural Cavity, Via Natural or Artificial Opening

3E0M05ZIntroduction of Adhesion Barrier into Peritoneal Cavity, Open Approach

3E0M304Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach

3E0M305Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach

3E0M30MIntroduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach

3E0M30YIntroduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach

3E0M328Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach

3E0M329Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach

3E0M33ZIntroduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach

3E0M35ZIntroduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Approach

3E0M36ZIntroduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach

3E0M37ZIntroduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach

3E0M3BZIntroduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach

3E0M3GCIntroduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach

3E0M3HZIntroduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach

3E0M3KZIntroduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach

3E0M3NZIntroduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach

3E0M3SFIntroduction of Other Gas into Peritoneal Cavity, Percutaneous Approach

3E0M3TZIntroduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach

3E0M45ZIntroduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Endoscopic Approach

3E0M4GCIntroduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Endoscopic Approach

3E0M704Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening

3E0M705Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening

3E0M70MIntroduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening

3E0M7SFIntroduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening

3E0N304Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Percutaneous Approach

3E0N305Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach

3E0N30MIntroduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach

3E0N328Introduction of Oxazolidinones into Male Reproductive, Percutaneous Approach

3E0N329Introduction of Other Anti-infective into Male Reproductive, Percutaneous Approach

3E0N33ZIntroduction of Anti-inflammatory into Male Reproductive, Percutaneous Approach

3E0N36ZIntroduction of Nutritional Substance into Male Reproductive, Percutaneous Approach

3E0N37ZIntroduction of Electrolytic and Water Balance Substance into Male Reproductive, Percutaneous Approach

3E0N3BZIntroduction of Anesthetic Agent into Male Reproductive, Percutaneous Approach

3E0N3GCIntroduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Approach

3E0N3HZIntroduction of Radioactive Substance into Male Reproductive, Percutaneous Approach

3E0N3KZIntroduction of Other Diagnostic Substance into Male Reproductive, Percutaneous Approach

3E0N3NZIntroduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Percutaneous Approach

3E0N3SFIntroduction of Other Gas into Male Reproductive, Percutaneous Approach

3E0N3TZIntroduction of Destructive Agent into Male Reproductive, Percutaneous Approach

3E0N4GCIntroduction of Other Therapeutic Substance into Male Reproductive, Percutaneous Endoscopic Approach

3E0N704Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening

3E0N705Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening

3E0N70MIntroduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening

3E0N728Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening

3E0N729Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening

3E0N73ZIntroduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening

3E0N76ZIntroduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening

3E0N77ZIntroduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening

3E0N7BZIntroduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening

3E0N7GCIntroduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening

3E0N7HZIntroduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening

3E0N7KZIntroduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening

3E0N7NZIntroduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening

3E0N7SFIntroduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening

3E0N7TZIntroduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening

3E0N804Introduction of Liquid Brachytherapy Radioisotope into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N805Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N80MIntroduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N828Introduction of Oxazolidinones into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N829Introduction of Other Anti-infective into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N83ZIntroduction of Anti-inflammatory into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N86ZIntroduction of Nutritional Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N87ZIntroduction of Electrolytic and Water Balance Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N8BZIntroduction of Anesthetic Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N8GCIntroduction of Other Therapeutic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N8HZIntroduction of Radioactive Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N8KZIntroduction of Other Diagnostic Substance into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N8NZIntroduction of Analgesics, Hypnotics, Sedatives into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N8SFIntroduction of Other Gas into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0N8TZIntroduction of Destructive Agent into Male Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P05ZIntroduction of Adhesion Barrier into Female Reproductive, Open Approach

3E0P304Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Percutaneous Approach

3E0P305Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach

3E0P30MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach

3E0P328Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach

3E0P329Introduction of Other Anti-infective into Female Reproductive, Percutaneous Approach

3E0P33ZIntroduction of Anti-inflammatory into Female Reproductive, Percutaneous Approach

3E0P35ZIntroduction of Adhesion Barrier into Female Reproductive, Percutaneous Approach

3E0P36ZIntroduction of Nutritional Substance into Female Reproductive, Percutaneous Approach

3E0P37ZIntroduction of Electrolytic and Water Balance Substance into Female Reproductive, Percutaneous Approach

3E0P3BZIntroduction of Anesthetic Agent into Female Reproductive, Percutaneous Approach

3E0P3GCIntroduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Approach

3E0P3HZIntroduction of Radioactive Substance into Female Reproductive, Percutaneous Approach

3E0P3KZIntroduction of Other Diagnostic Substance into Female Reproductive, Percutaneous Approach

3E0P3LZIntroduction of Sperm into Female Reproductive, Percutaneous Approach

3E0P3NZIntroduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Percutaneous Approach

3E0P3Q0Introduction of Autologous Fertilized Ovum into Female Reproductive, Percutaneous Approach

3E0P3Q1Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach

3E0P3SFIntroduction of Other Gas into Female Reproductive, Percutaneous Approach

3E0P3TZIntroduction of Destructive Agent into Female Reproductive, Percutaneous Approach

3E0P3VZIntroduction of Hormone into Female Reproductive, Percutaneous Approach

3E0P45ZIntroduction of Adhesion Barrier into Female Reproductive, Percutaneous Endoscopic Approach

3E0P4GCIntroduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Endoscopic Approach

3E0P704Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening

3E0P705Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening

3E0P70MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening

3E0P728Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening

3E0P729Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening

3E0P73ZIntroduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening

3E0P76ZIntroduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening

3E0P77ZIntroduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening

3E0P7BZIntroduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening

3E0P7GCIntroduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening

3E0P7HZIntroduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening

3E0P7KZIntroduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening

3E0P7LZIntroduction of Sperm into Female Reproductive, Via Natural or Artificial Opening

3E0P7NZIntroduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening

3E0P7Q0Introduction of Autologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening

3E0P7Q1Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening

3E0P7SFIntroduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening

3E0P7TZIntroduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening

3E0P7VZIntroduction of Hormone into Female Reproductive, Via Natural or Artificial Opening

3E0P804Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P805Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P80MIntroduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P828Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P829Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P83ZIntroduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P86ZIntroduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P87ZIntroduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P8BZIntroduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P8GCIntroduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P8HZIntroduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P8KZIntroduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P8NZIntroduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P8SFIntroduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0P8TZIntroduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic

3E0Q004Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Open Approach

3E0Q005Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach

3E0Q00MIntroduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach

3E0Q028Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach

3E0Q029Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach

3E0Q03ZIntroduction of Anti-inflammatory into Cranial Cavity and Brain, Open Approach

3E0Q06ZIntroduction of Nutritional Substance into Cranial Cavity and Brain, Open Approach

3E0Q07ZIntroduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Open Approach

3E0Q0AZIntroduction of Embryonic Stem Cells into Cranial Cavity and Brain, Open Approach

3E0Q0BZIntroduction of Anesthetic Agent into Cranial Cavity and Brain, Open Approach

3E0Q0E0Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach

3E0Q0E1Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Open Approach

3E0Q0GCIntroduction of Other Therapeutic Substance into Cranial Cavity and Brain, Open Approach

3E0Q0HZIntroduction of Radioactive Substance into Cranial Cavity and Brain, Open Approach

3E0Q0KZIntroduction of Other Diagnostic Substance into Cranial Cavity and Brain, Open Approach

3E0Q0NZIntroduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Open Approach

3E0Q0SFIntroduction of Other Gas into Cranial Cavity and Brain, Open Approach

3E0Q0TZIntroduction of Destructive Agent into Cranial Cavity and Brain, Open Approach

3E0Q304Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Percutaneous Approach

3E0Q305Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach

3E0Q30MIntroduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach

3E0Q328Introduction of Oxazolidinones into Cranial Cavity and Brain, Percutaneous Approach

3E0Q329Introduction of Other Anti-infective into Cranial Cavity and Brain, Percutaneous Approach

3E0Q33ZIntroduction of Anti-inflammatory into Cranial Cavity and Brain, Percutaneous Approach

3E0Q36ZIntroduction of Nutritional Substance into Cranial Cavity and Brain, Percutaneous Approach

3E0Q37ZIntroduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3AZIntroduction of Embryonic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3BZIntroduction of Anesthetic Agent into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3E0Introduction of Autologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3E1Introduction of Nonautologous Somatic Stem Cells into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3GCIntroduction of Other Therapeutic Substance into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3HZIntroduction of Radioactive Substance into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3KZIntroduction of Other Diagnostic Substance into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3NZIntroduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3SFIntroduction of Other Gas into Cranial Cavity and Brain, Percutaneous Approach

3E0Q3TZIntroduction of Destructive Agent into Cranial Cavity and Brain, Percutaneous Approach

3E0Q704Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Via Natural or Artificial Opening

3E0Q705Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening

3E0Q70MIntroduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening

3E0Q7SFIntroduction of Other Gas into Cranial Cavity and Brain, Via Natural or Artificial Opening

3E0R0AZIntroduction of Embryonic Stem Cells into Spinal Canal, Open Approach

3E0R0E0Introduction of Autologous Somatic Stem Cells into Spinal Canal, Open Approach

3E0R0E1Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Open Approach

3E0R302Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach

3E0R303Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach

3E0R304Introduction of Liquid Brachytherapy Radioisotope into Spinal Canal, Percutaneous Approach

3E0R305Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach

3E0R30MIntroduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach

3E0R328Introduction of Oxazolidinones into Spinal Canal, Percutaneous Approach

3E0R329Introduction of Other Anti-infective into Spinal Canal, Percutaneous Approach

3E0R33ZIntroduction of Anti-inflammatory into Spinal Canal, Percutaneous Approach

3E0R36ZIntroduction of Nutritional Substance into Spinal Canal, Percutaneous Approach

3E0R37ZIntroduction of Electrolytic and Water Balance Substance into Spinal Canal, Percutaneous Approach

3E0R3AZIntroduction of Embryonic Stem Cells into Spinal Canal, Percutaneous Approach

3E0R3BZIntroduction of Anesthetic Agent into Spinal Canal, Percutaneous Approach

3E0R3E0Introduction of Autologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach

3E0R3E1Introduction of Nonautologous Somatic Stem Cells into Spinal Canal, Percutaneous Approach

3E0R3GCIntroduction of Other Therapeutic Substance into Spinal Canal, Percutaneous Approach

3E0R3HZIntroduction of Radioactive Substance into Spinal Canal, Percutaneous Approach

3E0R3KZIntroduction of Other Diagnostic Substance into Spinal Canal, Percutaneous Approach

3E0R3NZIntroduction of Analgesics, Hypnotics, Sedatives into Spinal Canal, Percutaneous Approach

3E0R3SFIntroduction of Other Gas into Spinal Canal, Percutaneous Approach

3E0R3TZIntroduction of Destructive Agent into Spinal Canal, Percutaneous Approach

3E0R7SFIntroduction of Other Gas into Spinal Canal, Via Natural or Artificial Opening

3E0S302Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach

3E0S303Introduction of Low-dose Interleukin-2 into Epidural Space, Percutaneous Approach

3E0S304Introduction of Liquid Brachytherapy Radioisotope into Epidural Space, Percutaneous Approach

3E0S305Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach

3E0S30MIntroduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach

3E0S328Introduction of Oxazolidinones into Epidural Space, Percutaneous Approach

3E0S329Introduction of Other Anti-infective into Epidural Space, Percutaneous Approach

3E0S33ZIntroduction of Anti-inflammatory into Epidural Space, Percutaneous Approach

3E0S36ZIntroduction of Nutritional Substance into Epidural Space, Percutaneous Approach

3E0S37ZIntroduction of Electrolytic and Water Balance Substance into Epidural Space, Percutaneous Approach

3E0S3BZIntroduction of Anesthetic Agent into Epidural Space, Percutaneous Approach

3E0S3GCIntroduction of Other Therapeutic Substance into Epidural Space, Percutaneous Approach

3E0S3HZIntroduction of Radioactive Substance into Epidural Space, Percutaneous Approach

3E0S3KZIntroduction of Other Diagnostic Substance into Epidural Space, Percutaneous Approach

3E0S3NZIntroduction of Analgesics, Hypnotics, Sedatives into Epidural Space, Percutaneous Approach

3E0S3SFIntroduction of Other Gas into Epidural Space, Percutaneous Approach

3E0S3TZIntroduction of Destructive Agent into Epidural Space, Percutaneous Approach

3E0S7SFIntroduction of Other Gas into Epidural Space, Via Natural or Artificial Opening

3E0T33ZIntroduction of Anti-inflammatory into Peripheral Nerves and Plexi, Percutaneous Approach

3E0T3BZIntroduction of Anesthetic Agent into Peripheral Nerves and Plexi, Percutaneous Approach

3E0T3GCIntroduction of Other Therapeutic Substance into Peripheral Nerves and Plexi, Percutaneous Approach

3E0T3TZIntroduction of Destructive Agent into Peripheral Nerves and Plexi, Percutaneous Approach

3E0U028Introduction of Oxazolidinones into Joints, Open Approach

3E0U029Introduction of Other Anti-infective into Joints, Open Approach

3E0U0GBIntroduction of Recombinant Bone Morphogenetic Protein into Joints, Open Approach

3E0U304Introduction of Liquid Brachytherapy Radioisotope into Joints, Percutaneous Approach

3E0U305Introduction of Other Antineoplastic into Joints, Percutaneous Approach

3E0U30MIntroduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach

3E0U328Introduction of Oxazolidinones into Joints, Percutaneous Approach

3E0U329Introduction of Other Anti-infective into Joints, Percutaneous Approach

3E0U33ZIntroduction of Anti-inflammatory into Joints, Percutaneous Approach

3E0U36ZIntroduction of Nutritional Substance into Joints, Percutaneous Approach

3E0U37ZIntroduction of Electrolytic and Water Balance Substance into Joints, Percutaneous Approach

3E0U3BZIntroduction of Anesthetic Agent into Joints, Percutaneous Approach

3E0U3GBIntroduction of Recombinant Bone Morphogenetic Protein into Joints, Percutaneous Approach

3E0U3GCIntroduction of Other Therapeutic Substance into Joints, Percutaneous Approach

3E0U3HZIntroduction of Radioactive Substance into Joints, Percutaneous Approach

3E0U3KZIntroduction of Other Diagnostic Substance into Joints, Percutaneous Approach

3E0U3NZIntroduction of Analgesics, Hypnotics, Sedatives into Joints, Percutaneous Approach

3E0U3SFIntroduction of Other Gas into Joints, Percutaneous Approach

3E0U3TZIntroduction of Destructive Agent into Joints, Percutaneous Approach

3E0U4GCIntroduction of Other Therapeutic Substance into Joints, Percutaneous Endoscopic Approach

3E0V0GBIntroduction of Recombinant Bone Morphogenetic Protein into Bones, Open Approach

3E0V0GCIntroduction of Other Therapeutic Substance into Bones, Open Approach

3E0V305Introduction of Other Antineoplastic into Bones, Percutaneous Approach

3E0V30MIntroduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach

3E0V328Introduction of Oxazolidinones into Bones, Percutaneous Approach

3E0V329Introduction of Other Anti-infective into Bones, Percutaneous Approach

3E0V33ZIntroduction of Anti-inflammatory into Bones, Percutaneous Approach

3E0V36ZIntroduction of Nutritional Substance into Bones, Percutaneous Approach

3E0V37ZIntroduction of Electrolytic and Water Balance Substance into Bones, Percutaneous Approach

3E0V3BZIntroduction of Anesthetic Agent into Bones, Percutaneous Approach

3E0V3GBIntroduction of Recombinant Bone Morphogenetic Protein into Bones, Percutaneous Approach

3E0V3GCIntroduction of Other Therapeutic Substance into Bones, Percutaneous Approach

3E0V3HZIntroduction of Radioactive Substance into Bones, Percutaneous Approach

3E0V3KZIntroduction of Other Diagnostic Substance into Bones, Percutaneous Approach

3E0V3NZIntroduction of Analgesics, Hypnotics, Sedatives into Bones, Percutaneous Approach

3E0V3TZIntroduction of Destructive Agent into Bones, Percutaneous Approach

3E0V4GCIntroduction of Other Therapeutic Substance into Bones, Percutaneous Endoscopic Approach

3E0W305Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach

3E0W30MIntroduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach

3E0W328Introduction of Oxazolidinones into Lymphatics, Percutaneous Approach

3E0W329Introduction of Other Anti-infective into Lymphatics, Percutaneous Approach

3E0W33ZIntroduction of Anti-inflammatory into Lymphatics, Percutaneous Approach

3E0W36ZIntroduction of Nutritional Substance into Lymphatics, Percutaneous Approach

3E0W37ZIntroduction of Electrolytic and Water Balance Substance into Lymphatics, Percutaneous Approach

3E0W3BZIntroduction of Anesthetic Agent into Lymphatics, Percutaneous Approach

3E0W3GCIntroduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach

3E0W3HZIntroduction of Radioactive Substance into Lymphatics, Percutaneous Approach

3E0W3KZIntroduction of Other Diagnostic Substance into Lymphatics, Percutaneous Approach

3E0W3NZIntroduction of Analgesics, Hypnotics, Sedatives into Lymphatics, Percutaneous Approach

3E0W3TZIntroduction of Destructive Agent into Lymphatics, Percutaneous Approach

3E0X33ZIntroduction of Anti-inflammatory into Cranial Nerves, Percutaneous Approach

3E0X3BZIntroduction of Anesthetic Agent into Cranial Nerves, Percutaneous Approach

3E0X3GCIntroduction of Other Therapeutic Substance into Cranial Nerves, Percutaneous Approach

3E0X3TZIntroduction of Destructive Agent into Cranial Nerves, Percutaneous Approach

3E0Y304Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Percutaneous Approach

3E0Y305Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach

3E0Y30MIntroduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach

3E0Y328Introduction of Oxazolidinones into Pericardial Cavity, Percutaneous Approach

3E0Y329Introduction of Other Anti-infective into Pericardial Cavity, Percutaneous Approach

3E0Y33ZIntroduction of Anti-inflammatory into Pericardial Cavity, Percutaneous Approach

3E0Y36ZIntroduction of Nutritional Substance into Pericardial Cavity, Percutaneous Approach

3E0Y37ZIntroduction of Electrolytic and Water Balance Substance into Pericardial Cavity, Percutaneous Approach

3E0Y3BZIntroduction of Anesthetic Agent into Pericardial Cavity, Percutaneous Approach

3E0Y3GCIntroduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach

3E0Y3HZIntroduction of Radioactive Substance into Pericardial Cavity, Percutaneous Approach

3E0Y3KZIntroduction of Other Diagnostic Substance into Pericardial Cavity, Percutaneous Approach

3E0Y3NZIntroduction of Analgesics, Hypnotics, Sedatives into Pericardial Cavity, Percutaneous Approach

3E0Y3SFIntroduction of Other Gas into Pericardial Cavity, Percutaneous Approach

3E0Y3TZIntroduction of Destructive Agent into Pericardial Cavity, Percutaneous Approach

3E0Y4GCIntroduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach

3E0Y704Introduction of Liquid Brachytherapy Radioisotope into Pericardial Cavity, Via Natural or Artificial Opening

3E0Y705Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening

3E0Y70MIntroduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening

3E0Y7SFIntroduction of Other Gas into Pericardial Cavity, Via Natural or Artificial Opening

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue